Answers are grounded in this paper and cite their sources.
The purpose of this study was to compare the immune response generated by the intramuscular and the intradermal vaccination route against the porcine reproductive and respiratory syndrome virus (PRRSV). Piglets from a seronegative and a seropositive farm were selected (n = 28 piglets per farm), and each group was divided into two groups and vaccinated at weaning with modified live vaccine Unistrain® PRRS (Laboratorios Hipra Amer, Spain) by the intramuscular or the intradermic route. For the following 6 weeks, animals were weekly bled to assess the humoral response by PRRSV-specific antibody ELISA and viral neutralisation test. At 0-, 3-, 4- and 6 weeks post-vaccination, peripheral mononuclear blood cells (PBMC) from eight animals per group were recovered to analyse cellular response by IFN-γ ELISPOT and lymphoproliferation. Serum IL-12 was also quantified by ELISA. Results showed no significant differences between treatments for any of the parameters studied. However, pigs from the seronegative origin had higher dispersion in S/P ratios by ELISA (Levene’s test for homogeneity of variances, p < 0.05). At 3 weeks after vaccination, 6/27 (22.22%) animals from negative origin had not seroconverted. Also, it was 10 times more probable for them to have high levels of IL-12 a week after vaccination than for animals of seropositive origin. These results indicate that the intradermal route induces an immune response equivalent to the classical intramuscular route even in presence of maternal immunity, which in this study has proven to facilitate seroconversion after vaccination.
No takes yet. Share an insight, caveat, or question.
Aguirre et al. (2022) studied this question.